Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Jun 30, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new treatment approach called semantic rehabilitation for people with primary progressive semantic aphasia, a condition that affects language and communication skills. The goal is to see how well this therapy works for patients who are experiencing mild to moderate dementia. If you or a loved one is between the ages of 18 and 74, speaks French, and has been diagnosed with this specific type of aphasia, you might be eligible to participate in the study.
Participants in the trial will receive the semantic rehabilitation treatment and will help researchers understand its effectiveness. However, there are certain criteria that could prevent someone from taking part, such as serious vision or hearing problems, past brain injuries, or untreated mental health issues. If you think this study might be a good fit for you or someone you know, it could be a valuable opportunity to contribute to research that aims to improve communication for those affected by this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have a diagnosis of primary progressive semantic aphasia according to the criteria of Gorno-Tempini et al (2011) (Appendix A)
- • Being in the mild to moderate stage of dementia (MMSE score between 10 and 28) (Crum et al., 1993; Derouesné et al., 1999)
- • Common French
- • Being affiliated to a social security scheme
- • Being over the age of 18 years old
- Exclusion Criteria:
- • Have significant uncorrected visual and/or hearing impairment
- • Have a history of brain injuries, major head trauma
- • Have untreated psychiatric disorders
- • Have significant motor and/or comprehension problems that make it impossible to take part in the study
- • Chronical use of drugs and/or alcohol
- • Under guardians or curators
- • Severe depression (Beck's depression scale score \> 9) (Beck \& al., 1961)
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Patients applied
Trial Officials
Jérémie PARIENTE, MD PhD
Principal Investigator
University Hospital, Toulouse
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials